Nelson Christopher M. 5
5 · QSAM Biosciences, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 5
Nelson Christopher M.
DirectorCEO
Transactions
- Award
COMMON STOCK
2020-10-26$0.22/sh+423,609$93,194→ 696,041 total - Award
SERIES E-1 PREFERRED STOCK
2020-12-30+850→ 850,000 totalExercise: $0.00From: 2020-12-30→ COMMON STOCK (850,000 underlying)
Holdings
- 11,400
Options to buy Common Stock
Exercise: $0.50From: 2015-11-18Exp: 2025-11-18→ COMMON STOCK (11,400 underlying)
Footnotes (2)
- [F1]Shares acquired upon conversion of accrued salary at a conversion price of $0.22 per share.
- [F2]Series E-1 preferred stock is convertible into common stock pursuant to terms of certificate of designation filed by the issuer on December 3, 2020.